甲状腺癌幸存者：挑战与机遇。

IF 3.7 3区医学 Q2 ENDOCRINOLOGY & METABOLISM

Endocrine Practice Pub Date : 2024-11-01 DOI:10.1016/j.eprac.2024.08.003

Anupam Kotwal MD, MSc, FACE , Abbey Fingeret MD, MHPTT, FACS , Anne Knape APRN-NP , Anery Patel MD , Elizabeth Bradford Bell MD , Whitney Goldner MD

{"title":"甲状腺癌幸存者：挑战与机遇。","authors":"Anupam Kotwal MD, MSc, FACE , Abbey Fingeret MD, MHPTT, FACS , Anne Knape APRN-NP , Anery Patel MD , Elizabeth Bradford Bell MD , Whitney Goldner MD","doi":"10.1016/j.eprac.2024.08.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To provide a narrative review of challenges and opportunities in the care of thyroid cancer survivors.</div></div><div><h3>Methods</h3><div>A literature search for full-text articles pertaining to quality of life and survivorship in thyroid cancer was performed and supplemented with personal experience of the authors.</div></div><div><h3>Results</h3><div>Despite usually favorable prognosis for most thyroid cancer survivors, health-related quality of life (HRQOL) can be as poor or even worse than that in more aggressive cancers. Worry of cancer recurrence and long-term effects from cancer treatment adversely affects HRQOL in addition to other factors. Disparities and financial hardships among thyroid cancer survivors further affect HRQOL. In addition to monitoring for cancer recurrence and managing hypothyroidism, long-term effects from cancer treatment, including surgical complications, effects from radioactive iodine therapy, a small but increased risk of second primary malignancies, and aging-related health conditions (bone, cardiac, and fertility), need to be monitored for and addressed during survivorship care.</div></div><div><h3>Conclusion</h3><div>Survivorship care models can vary depending on the specifics of the population served; however, a team-based survivor-centered approach provides the best care to thyroid cancer survivors.</div></div>","PeriodicalId":11682,"journal":{"name":"Endocrine Practice","volume":"30 11","pages":"Pages 1097-1102"},"PeriodicalIF":3.7000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Thyroid Cancer Survivorship: Challenges and Opportunities\",\"authors\":\"Anupam Kotwal MD, MSc, FACE , Abbey Fingeret MD, MHPTT, FACS , Anne Knape APRN-NP , Anery Patel MD , Elizabeth Bradford Bell MD , Whitney Goldner MD\",\"doi\":\"10.1016/j.eprac.2024.08.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>To provide a narrative review of challenges and opportunities in the care of thyroid cancer survivors.</div></div><div><h3>Methods</h3><div>A literature search for full-text articles pertaining to quality of life and survivorship in thyroid cancer was performed and supplemented with personal experience of the authors.</div></div><div><h3>Results</h3><div>Despite usually favorable prognosis for most thyroid cancer survivors, health-related quality of life (HRQOL) can be as poor or even worse than that in more aggressive cancers. Worry of cancer recurrence and long-term effects from cancer treatment adversely affects HRQOL in addition to other factors. Disparities and financial hardships among thyroid cancer survivors further affect HRQOL. In addition to monitoring for cancer recurrence and managing hypothyroidism, long-term effects from cancer treatment, including surgical complications, effects from radioactive iodine therapy, a small but increased risk of second primary malignancies, and aging-related health conditions (bone, cardiac, and fertility), need to be monitored for and addressed during survivorship care.</div></div><div><h3>Conclusion</h3><div>Survivorship care models can vary depending on the specifics of the population served; however, a team-based survivor-centered approach provides the best care to thyroid cancer survivors.</div></div>\",\"PeriodicalId\":11682,\"journal\":{\"name\":\"Endocrine Practice\",\"volume\":\"30 11\",\"pages\":\"Pages 1097-1102\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Endocrine Practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1530891X24006529\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine Practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1530891X24006529","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

摘要

目的对甲状腺癌幸存者护理过程中面临的挑战和机遇进行叙述性综述：方法：对有关甲状腺癌患者生活质量和生存期的全文进行文献检索，并结合作者的亲身经历进行补充：结果：尽管大多数甲状腺癌幸存者的预后通常良好，但与健康相关的生活质量（HRQOL）可能与侵袭性更强的癌症一样差，甚至更差。除其他因素外，担心癌症复发和癌症治疗的长期影响也会对HRQOL产生不利影响。甲状腺癌幸存者之间的差异和经济困难进一步影响了患者的 HRQOL。除了监测癌症复发和控制甲状腺功能减退症外，癌症治疗的长期影响，包括手术并发症、放射性碘治疗的影响、二次原发性恶性肿瘤的风险虽小但增加，以及与衰老相关的健康状况（骨骼、心脏、生育），都需要在幸存者关怀期间进行监测和处理：幸存者关怀模式可根据服务人群的具体情况而有所不同，但以团队为基础、以幸存者为中心的方法可为甲状腺癌幸存者提供最佳关怀。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Thyroid Cancer Survivorship: Challenges and Opportunities

Objective

To provide a narrative review of challenges and opportunities in the care of thyroid cancer survivors.

Methods

A literature search for full-text articles pertaining to quality of life and survivorship in thyroid cancer was performed and supplemented with personal experience of the authors.

Results

Despite usually favorable prognosis for most thyroid cancer survivors, health-related quality of life (HRQOL) can be as poor or even worse than that in more aggressive cancers. Worry of cancer recurrence and long-term effects from cancer treatment adversely affects HRQOL in addition to other factors. Disparities and financial hardships among thyroid cancer survivors further affect HRQOL. In addition to monitoring for cancer recurrence and managing hypothyroidism, long-term effects from cancer treatment, including surgical complications, effects from radioactive iodine therapy, a small but increased risk of second primary malignancies, and aging-related health conditions (bone, cardiac, and fertility), need to be monitored for and addressed during survivorship care.

Conclusion

Survivorship care models can vary depending on the specifics of the population served; however, a team-based survivor-centered approach provides the best care to thyroid cancer survivors.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Endocrine Practice ENDOCRINOLOGY & METABOLISM-

CiteScore

7.60

自引率

2.40%

发文量

546

审稿时长

41 days

期刊介绍： Endocrine Practice (ISSN: 1530-891X), a peer-reviewed journal published twelve times a year, is the official journal of the American Association of Clinical Endocrinologists (AACE). The primary mission of Endocrine Practice is to enhance the health care of patients with endocrine diseases through continuing education of practicing endocrinologists.